Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivaroxaban Sotorasib Interaction Study

NCT06314763 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT06314763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06314763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivaroxaban Sotorasib Interaction Study
Lead sponsor
Radboud University Medical Center
Phase
Phase 4
Overall status
Completed
Start date
November 9, 2023
Completion date
March 21, 2024
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug drug interaction study